EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circulating Calprotectin Distinguishes Metastatic Melanoma and Predicts Liver Metastasis

István Szász, Viktória Koroknai, Tünde Várvölgyi, Gabriella Emri iD, Imre Lőrinc Szabó iD, Margit Balázs iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26168028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von István Szász und 5 weiteren Autor:innen. Beteiligte Einrichtung: HUN-REN-UD Public Health Research Group, Department of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, 4028 Debrecen, Hu…. Hauptthemen laut MEDLINE: Melanoma, Leukocyte L1 Antigen Complex, Liver Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Development and Innovation Fund, European Regional Development Fund, HUN-REN Hungarian Research Network.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Calprotectin, a heterodimer of the S100A8 and S100A9 proteins, has been implicated in cancer-related inflammation and metastasis. Its role in melanoma progression, particularly in organ-specific metastasis, remains underexplored. In this retrospective study, plasma calprotectin levels were measured in 201 individuals, including healthy controls (n = 22), melanoma patients without evidence of metastasis (n = 71), and patients with metastatic melanoma (n = 108). Calprotectin concentrations were determined using the ELISA assay. Receiver operating characteristic (ROC) curve analyses were used to evaluate its diagnostic value, both alone and in combination with established biomarkers S100B and LDH. Plasma calprotectin levels were significantly elevated in patients with metastatic melanoma compared to non-metastatic patients (p < 0.001). Calprotectin showed moderate diagnostic value (AUC = 0.672), which improved to 0.755 when combined with S100B and LDH. Organ-specific analysis revealed that patients with liver metastases exhibited the highest calprotectin concentrations, with good discriminatory power (AUC = 0.710). No significant association was found between calprotectin levels and the type of metastasis identified (lymphatic vs. hematogenous). Logistic regression analysis showed that calprotectin levels above 2728 ng/mL were associated with a 7.4-fold increased risk of liver metastasis. Calprotectin is a promising blood-based biomarker that may enhance the detection of metastatic melanoma, particularly in cases with liver involvement. These findings suggest that calprotectin could be integrated into multivariable prediction models to improve risk stratification in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaLeukocyte L1 Antigen ComplexLiver NeoplasmsBiomarkers, TumorHumansMaleFemaleMiddle AgedAgedAdultRetrospective StudiesROC CurveS100 Calcium Binding Protein beta SubunitL-Lactate DehydrogenasePrognosis

Stichwörter der Autor:innen

S100B and LDHbiomarkercalprotectinliquid biopsyliver metastasismelanomaorgan specific metastasis

Substanzen

Leukocyte L1 Antigen ComplexBiomarkers, TumorS100 Calcium Binding Protein beta SubunitL-Lactate Dehydrogenase

Autor:innen und Institutionen

  • HUN-REN-UD Public Health Research Group, Department of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, 4028 Debrecen, Hungary.
  • Department of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, 4028 Debrecen, Hungary.
  • Department of Dermatology, Faculty of Medicine, University of Debrecen, 4028 Debrecen, Hungary.

ORCID-Profile: Gabriella Emri, Imre Lőrinc Szabó, Margit Balázs

Förderung

  • National Research Development and Innovation Fund
  • European Regional Development Fund
  • HUN-REN Hungarian Research Network
  • EKÖP-24-4 University Research Scholarship Program of the Ministry for Culture and Innovation from the source of the National Research Development and Innovatio…
  • University of Debrecen Program for Scientific Publication
  • University of Debrecen Scientific Research Bridging Fund

Zitieren

APA

Szász, I., Koroknai, V., Várvölgyi, T., Emri, G., Szabó, I. L., & Balázs, M. (2025). Circulating Calprotectin Distinguishes Metastatic Melanoma and Predicts Liver Metastasis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26168028

Vancouver

Szász I, Koroknai V, Várvölgyi T, Emri G, Szabó IL, Balázs M. Circulating Calprotectin Distinguishes Metastatic Melanoma and Predicts Liver Metastasis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26168028

BibTeX
@article{Szsz2025,
  author = {Szász, István and Koroknai, Viktória and Várvölgyi, Tünde and Emri, Gabriella and Szabó, Imre Lőrinc and Balázs, Margit},
  title = {Circulating Calprotectin Distinguishes Metastatic Melanoma and Predicts Liver Metastasis},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26168028}
}
Kostenlos starten →